Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024 [Yahoo! Finance]
Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024
Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now [Yahoo! Finance]
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients [Yahoo! Finance]